Pentabind Ltd
Private Limited Company · London
ActiveUnited KingdomIncorporated 2021Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-11-30
IXBRL · 89 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2025-11-30
IXBRL · 89 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-12-01 to 2025-11-30
- Extraction status
- complete
- Numeric facts
- 59
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2604_13759900_20251130
- Source archive
- Accounts_Monthly_Data-April2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-11-30
IXBRL · 49 source facts · 19 selected values
Validation findingsXBRL valid
Accounts to 2024-11-30
IXBRL · 49 source facts · 19 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-12-01 to 2024-11-30
- Extraction status
- complete
- Numeric facts
- 19
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2508_13759900_20241130
- Source archive
- Accounts_Monthly_Data-August2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-11-30
IXBRL · 55 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2023-11-30
IXBRL · 55 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2022-12-01 to 2023-11-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 27
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2466_13759900_20231130
- Source archive
- Accounts_Monthly_Data-August2024.zip
Accounts to 2022-11-30
IXBRL · 26 source facts · 7 selected values
Not assessedlegacy record
Accounts to 2022-11-30
IXBRL · 26 source facts · 7 selected values
Not assessed
legacy record
- Reporting period
- 2021-11-23 to 2022-11-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 7
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0008_13759900_20221130
- Source archive
- Accounts_Monthly_Data-March2023.zip
Registered details
13759900- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2021-11-23
- Jurisdiction
- —
- Registered office
- SCALE SPACE BUILDING, 58 WOOD LANE, LONDON, W12 7RZ, UNITED KINGDOM
Classification
1 SIC codes23011
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsAI-Guided Truncation and Chemical Optimisation of Aptamers for Cancer Therapeutics.Lead
Innovate UK · Collaborative R&D · 2025-09-01 – 2026-02-28
£49,000
awarded
R&D for an Integrated AI-Wet Laboratory Platform that Designs Receptor-Specific and Cell-Internalising AptamersLead
Innovate UK · Collaborative R&D · 2024-07-01 – 2025-01-31
£49,994
awarded
R&D for an Integrated AI-Wet Laboratory Platform that Designs Receptor-Specific and Cell-Internalising AptamersLead
TMF · Collaborative R&D · 2024-06-30 – 2025-01-31
£49,994
whole project
R&D for an Integrated AI-Wet Laboratory Platform that Designs Receptor-Specific and Cell-Internalising Aptamers
TMF · Collaborative R&D · 2024-06-30 – 2025-01-31
£49,994
whole project